Compound Detail
CHEMBL4174446
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4174446 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HSBGWPZAHKXBCW-IBGZPJMESA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
276.3
MW (Da)
1.67
ALogP
4
HBA
0
HBD
66.4
PSA (Ų)
0.62
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.05
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SNU-475 | IC50 | = | 9000.0 | nM | 5.05 | Cytotoxicity against human SNU475 cells assessed as growth inhibition after 72 h... | 30108693 |
| Hep 3B2 | IC50 | = | 9900.0 | nM | 5.0 | Cytotoxicity against human Hep3B cells assessed as growth inhibition after 72 hr... | 30108693 |
| Huh-7 | IC50 | = | 10600.0 | nM | 4.97 | Cytotoxicity against human HuH7 cells assessed as growth inhibition after 72 hrs... | 30108693 |
| Mahlavu | IC50 | = | 11300.0 | nM | 4.95 | Cytotoxicity against human Mahlavu cells assessed as growth inhibition after 72 ... | 30108693 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30108693 | 10.1039/C6MD00392C | Hep 3B2 | 4 |
| 30108693 | 10.1039/C6MD00392C | Huh-7 | 4 |
| 30108693 | 10.1039/C6MD00392C | Mahlavu | 3 |
| 30108693 | 10.1039/C6MD00392C | SNU-475 | 3 |
Data from ChEMBL 36 via Core Engine